Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_1
4
27%
Ph not_applicable
7
47%
Ph phase_2
1
7%
Ph phase_3
2
13%
Ph phase_4
1
7%

Phase Distribution

4

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
4(26.7%)
Phase 2Efficacy & side effects
1(6.7%)
Phase 3Large-scale testing
2(13.3%)
Phase 4Post-market surveillance
1(6.7%)
N/ANon-phased studies
7(46.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.6%

11 of 13 finished

Non-Completion Rate

15.4%

2 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Completed(11)
Terminated(2)
Other(2)

Detailed Status

Completed11
unknown2
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (26.7%)
Phase 21 (6.7%)
Phase 32 (13.3%)
Phase 41 (6.7%)
N/A7 (46.7%)

Trials by Status

completed1173%
withdrawn17%
terminated17%
unknown213%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT00001054Phase 1

The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children

Withdrawn
NCT00079911Phase 4

A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons

Terminated
NCT00487682Phase 2

Dose-finding Study of ASP2151 in Subjects With Herpes Zoster

Completed
NCT01132729Not Applicable

Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions

Completed
NCT01132716Not Applicable

Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions

Completed
NCT00001038Phase 3

A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients

Completed
NCT01222897Not Applicable

A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fed Condition

Completed
NCT01222910Not Applicable

A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fasting Condition

Completed
NCT01136538Phase 1

Bioavailability Study of Valacycovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fed Condition

Completed
NCT01136525Phase 1

Bioavailability Study of Valacyclovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fasting Conditions

Completed
NCT00002404Not Applicable

The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected Patients

Completed
NCT00587496Phase 1

30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers

Unknown
NCT00002000Not Applicable

A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients

Completed
NCT00005663Phase 3

A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients

Unknown
NCT00002084Not Applicable

A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15